Protective effects of benidipine hydrochloride (KW-3049), a calcium antagonist, against experimental arterial calcinosis and endothelial dysfunction in rats.
Protective effects of benidipine hydrochloride (KW-3049) against arterial calcinosis and its possible mechanisms of action have been investigated. Arterial calcinosis was induced in rats by combined administration of vitamin D2 (1050000 IU/kg, s.c.) and nicotine (12.5 mg/kg, p.o., b.i.d.) for 6 successive days. Calcium antagonists, benidipine or nifedipine, were given orally twice a day during the same period. The aortic calcium content in vitamin D2 and nicotine-treated (control) rats increased to about 25 times that in normal rats, accompanying an increase of serum calcium level. Benidipine (10 mg/kg, p.o., b.i.d.) reduced the aortic calcium content to about 18% of control rats without reducing the serum calcium level. Although the presence of aortic endothelial cells was observed under light microscopy in control rats, their surfaces were degenerated under scanning electron microscopy. Benidipine exerted a protective effect against these degenerative changes. Acetylcholine-induced endothelial dependent relaxation was attenuated in control rats, compared with that in normal rats. Benidipine significantly improved this attenuation of the relaxation. These results suggest that the anticalcinotic effect of benidipine is accompanied by its protective effect on endothelial cells.
Higo
K
K
Department of Pharmacology, Kyowa Hakko Kogyo Co., Ltd., Shizuoka, Japan.
Karasawa
A
A
Kubo
K
K
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001011:Aorta / Q000737:chemistry / Q000473:pathology / Q000648:ultrastructure; D001158:Arteries / Q000473:pathology*; D002114:Calcinosis / Q000139:chemically induced / Q000517:prevention & control*; D002118:Calcium / Q000032:analysis; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D004730:Endothelium, Vascular / Q000503:physiopathology* / Q000648:ultrastructure; D004872:Ergocalciferols / Q000633:toxicity; D008297:Male; D008855:Microscopy, Electron, Scanning; D009126:Muscle Relaxation / Q000187:drug effects; D009131:Muscle, Smooth, Vascular / Q000187:drug effects; D009538:Nicotine / Q000633:toxicity; D009543:Nifedipine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D051381:Rats; D011919:Rats, Inbred Strains
D002121:Calcium Channel Blockers; D004872:Ergocalciferols; C050883:benidipine hydrochloride; D009538:Nicotine; D009543:Nifedipine; D000109:Acetylcholine; D002118:Calcium